A bisphenol that is 4,4'-methanediyldiphenol in which the methylene hydrogens are replaced by two methyl groups.
Chemical ID:
MESH:C006780
Note: Use of the qualifier "multiple interactions" designates that the annotated interaction
is comprised of a complex set of reactions and/or regulatory events, possibly involving
additional chemicals and/or gene products.
[bisphenol A co-treated with Diethylhexyl Phthalate co-treated with diethyl phthalate co-treated with diisononyl phthalate co-treated with di-n-octyl phthalate co-treated with Dibutyl Phthalate co-treated with butylbenzyl phthalate co-treated with diisodecyl phthalate] results in decreased expression of NFE2L2 mRNA; bisphenol A promotes the reaction [NFE2L2 protein binds to SREBF1 promoter]; bisphenol A results in decreased expression of and results in increased methylation of NFE2L2 mRNA
bisphenol A analog results in decreased expression of NFE2L2 mRNA; bisphenol A analog results in decreased expression of NFE2L2 protein; bisphenol A results in decreased expression of NFE2L2 mRNA; bisphenol A results in decreased expression of NFE2L2 protein
Fluvastatin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein]; Fluvastatin promotes the reaction [taxifolin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein]]; Luteolin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein]; Resveratrol analog inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein]; taxifolin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein]; taxifolin promotes the reaction [Fluvastatin inhibits the reaction [bisphenol A results in decreased expression of NFE2L2 protein]]
2-(7-(3,4-dimethoxyphenyl)imidazo(1,2-c)pyrimidin-5-ylamino)nicotinamide inhibits the reaction [bisphenol A results in increased expression of NFE2L2 protein]; 2-aminoethoxydiphenylborane inhibits the reaction [bisphenol A results in increased expression of NFE2L2 protein]; [ALB protein co-treated with bisphenol A] results in increased expression of NFE2L2 mRNA; Acetylcysteine inhibits the reaction [bisphenol A results in increased expression of NFE2L2 protein]; bisphenol A promotes the reaction [NFE2L2 protein binds to ATG7 promoter]; bisphenol A promotes the reaction [NFE2L2 protein binds to BECN1 promoter]; bisphenol A results in increased expression of and affects the localization of NFE2L2 protein; ITPR1 protein inhibits the reaction [bisphenol A results in increased expression of NFE2L2 protein]; NFE2L2 protein affects the reaction [bisphenol A results in increased expression of ATG7 mRNA]; NFE2L2 protein affects the reaction [bisphenol A results in increased expression of ATG7 protein]; NFE2L2 protein affects the reaction [bisphenol A results in increased expression of BECN1 mRNA]; NFE2L2 protein affects the reaction [bisphenol A results in increased expression of BECN1 protein]
